RTW Biotech Opportunities plans USD42.8 million further share buyback

RTW Biotech Opportunities Ltd on Monday said it will allocate a further USD42.8 million to share buybacks as an initial programme nears completion.

The London-listed investor in the life sciences sector noted it has returned USD42.3 million of its previous USD45 million commitment to shareholders through share buybacks, including the repurchase of 7.2 million shares in the year to November 5.

Under new plans, RTW said it will allocate a further USD42.8 million to a liquidity pool, around 4.9% of net asset value, for "NAV-accretive" share buybacks.

This forms part of a formal policy to allocate up to 20% of realised gains from M&A transactions to a liquidity pool that can be used to return capital to shareholders, the firm explained.

RTW said a "more formulaic capital allocation plan would provide shareholders with greater clarity on returns."

The returns will allow shareholders "to participate in the liquidity generated from successful investment exits," the firm said, noting biotech M&A has rebounded sharply in 2025 and 2026.

Shares in RTW were up 0.9% to USD2.36 per share on Monday morning in London.

Copyright 2026 Alliance News Ltd. All Rights Reserved.